
Über diesen Podcast
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in cardiology, pulmonology. Earning your CME/CE credit has never been faster or…
58 Folgen · science
CME in Minutes: Education in Cardiology & Pulmonology
Über diesen Podcast
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in cardiology, pulmonology. Earning your CME/CE credit has never been faster or…
Neue Folgen
- From Biology to Best Practice: Sequencing Current and Emerging Therapies in EGFR-Mutated NSCLC Beyond Progression12. Aug. · 36 Min.
- Adapting to Evolution for Second-Line Treatment in EGFR-Mutated Advanced NSCLC: Understanding Tumor Biology to Elevate the Therapeutic Strategy5. Aug. · 32 Min.
- Designing the Foundation: Optimizing First-Line Therapy for EGFR-Mutated Advanced NSCLC24. Juli · 32 Min.
- Practical Conversations on PAH Care: Risk-Based Strategies for Specialists in the Community3. Juli · 22 Min.
- The Next Chapter in Fibrosing ILD Care: Integrating Emerging Data on Novel Antifibrotics Into Multidisciplinary Practice16. Juni · 1 Std. 05 Min.
- Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC11. Juni · 19 Min.
- The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking New Treatment Opportunities With a Familiar Target5. Juni · 1 Std. 14 Min.
- Cracking the Code of KRAS-Mutant NSCLC: Evidence for Emerging Therapies in First-Line Settings13. Mai · 14 Min.
- Reducing Cardiometabolic Risk: What Cardiovascular Outcomes Trials Tell Us About Incretin-Based Therapies29. Apr. · 16 Min.
- Advancing Secondary Stroke Prevention: How the Latest Evidence Informs Team-Based Practice27. Apr. · 1 Std. 02 Min.